Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 33 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Lumbosacral Radiculopathy Clear all

Conditions: Neuropathic Pain From Lumbosacral Radiculopathy
Interventions: KLS-2031, Placebo; Drug · Other
Lead sponsor: Kolon Life Science; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Lumbosacral Radiculopathy
Interventions: z160, Placebo; Drug
Lead sponsor: Zalicus; Industry
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 23
States / cities: Huntsville, Alabama • Peoria, Arizona • Anaheim, California + 19 more

Conditions: Lumbosacral Radicular Pain
Interventions: SP-102, Placebo; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 37
States / cities: Mobile, Alabama • Phoenix, Arizona • Tempe, Arizona + 30 more

Conditions: Radiculopathy, Lumbosacral Region, Back Pain With Radiation, Low Back Pain
Interventions: Ibuprofen 400 mg, Dexamethasone Oral, Educational Intervention; Drug · Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Lumbosacral Radiculopathy
Interventions: Behavioral manipulation of ESI expectations, No behavioral manipulation of ESI expectations, No behavioral manipulation of pharmacotherapy expectations; Behavioral · Other
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois • Bethesda, Maryland

Conditions: Lumbosacral Radicular Pain, Sciatic Radiculopathy, Sciatic Leg Pain, Sciatica, Lumbosacral Radicular Syndrome, Lumbosacral Radiculopathy
Interventions: C-1101, Placebo: Sterile Saline; Drug · Other
Lead sponsor: Consano Bio; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Fernandina Beach, Florida • Winston-Salem, North Carolina • Richmond, Virginia

Conditions: Lumbar and Other Intervertebral Disc Disorders With Radiculopathy
Interventions: Clonidine, Triamcinolone hexacetonide, Lidocaine HCl; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Disc Herniation, Lumbosacral Radiculopathy
Interventions: CT-guided corticosteroid+ bupivicaine, Standard medical care; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 21 Years to 50 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Lumbosacral Radiculopathy
Interventions: KLS-2031; Drug
Lead sponsor: Kolon Life Science; Industry
Eligibility: Not listed
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Lower Back Pain, Lumbosacral Radiculopathy
Interventions: Qutenza® 8% Capsaicin Topical System; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Summerville, South Carolina

Conditions: Lumbosacral Radiculopathy, Lumbar Herniated Nucleus Pulposus
Interventions: Not listed
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Compression of Spinal Nerve Root, Spinal Disorder, Low Back Pain
Interventions: Sitting posture; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lumbosacral Radiculopathy, Lumbar Radiculopathy
Interventions: Platelet lysate, Saline control; Other
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Broomfield, Colorado

Conditions: Lumbar Radiculopathy
Interventions: Mindfulness Oriented Recovery Enhancement; Other
Lead sponsor: National University of Natural Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Radiculopathy Lumbar, Degenerative Lumbar Disc Disease
Interventions: Supplemental Posterior Fusion with Study Device, Supplemental Posterior Fusion with Standard Technique; Device
Lead sponsor: Providence Medical Technology, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 12
States / cities: Scottsdale, Arizona • Los Angeles, California • Los Gatos, California + 8 more

Conditions: Unilateral Lumbosacral Radiculopathy Pain
Interventions: Midline vs Parasagittal Lumbar Epidural Steroid Injection; Procedure
Lead sponsor: Kenneth D Candido; Other
Eligibility: 18 Years to 80 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lumbar Spine Degeneration
Interventions: INFUSE Bone Graft, Iliac Crest Bone Graft; Device · Other
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 5
States / cities: Mesa, Arizona • Los Angeles, California • Gulf Breeze, Florida + 2 more

Conditions: Sciatica, Herniated Disc, Radiculopathy
Interventions: REN-1654; Drug
Lead sponsor: Renovis; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 19
States / cities: Birmingham, Alabama • Tuscon, Arizona • Stanford, California + 15 more

Conditions: Lumbosacral Radiculopathy, Sciatica, Chronic Low Back Pain With a Neuropathic Component, Radiculopathy Lumbar, Chronic Pain (Back / Neck)
Interventions: Move-MORE; Behavioral
Lead sponsor: National University of Natural Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Lumbosacral Radiculopathy
Interventions: ETX-018810, Placebo; Drug
Lead sponsor: Eliem Therapeutics (UK) Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 24
States / cities: Mobile, Alabama • Phoenix, Arizona • Greenwood Village, Colorado + 18 more

Conditions: Radiculopathy Lumbar, Radiculopathy Sacral, Radiculopathy Multiple Sites
Interventions: Neubie Direct Current Electrical Stimulation Device, Transcutaneous Electrical Stimulation; Device
Lead sponsor: NeuFit - Neurological Fitness and Education; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 16
States / cities: Escondido, California • Cape Coral, Florida • Clearwater, Florida + 11 more

Conditions: Lumbosacral Radiculopathy
Interventions: Clonidine Micropellets, Sham; Combination Product · Other
Lead sponsor: Sollis Therapeutics, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 33
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 28 more

Conditions: Lumbosacral Radiculopathy
Interventions: Epidural steroid injection, Magnetic Resonance Imaging (MRI); Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Lumbosacral Radiculopathy
Interventions: Long-Term Safety Follow-up; Drug
Lead sponsor: Sollis Therapeutics, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 25
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 21 more

Search by objective public record fields.

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.

Procedural Framing and Epidural Steroid Injection Outcomes

Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy

Epidural Clonidine for Lumbosacral Radiculopathy

CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial

A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy

Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.

Soleus H-Reflex in Different Sitting Postures

Platelet Lysate vs Saline for Lumbosacral Radiculopathy

MORE in the Management of Lumbosacral Radiculopathy Symptoms: A Randomized Controlled Trial

Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes

Two Different Approaches During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

Study of REN-1654 in Patients With Sciatica Pain

A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy

Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Does Magnetic Resonance Imaging (MRI) Improve Interventional Outcomes for Lumbosacral Radiculopathy?

Long-Term Follow-up Safety of Clonidine Micropellets